2.5 Mesenchymal Stem Cell Therapy has significant clinical effect in proteoglycan induced arthritis

Ítems similars

• Mesenchymal stem cells and JIA
  per: Swart, JF, et al.
  Publicat: (2011)
• Recombinant IL1-RA in the early phase of systemic onset JIA: before the onset of arthritis
  per: Vastert, SJ, et al.
  Publicat: (2011)
• 4.5 Defective phosphorylation of the interleukin 18 receptor beta-chain causes impaired NK cell function in systemic onset Juvenile Idiopathic Arthritis
  per: de Jager, W, et al.
  Publicat: (2008)
• PReS-FINAL-2181: Recombinant il-1ra restores the il-18-nk cell axis in steroid naive systemic juvenile idiopathic arthritis
  per: De Jager, W, et al.
  Publicat: (2013)
• Akinra restores the defective IL-18 NK cell axis in steroid naïve systemic onset JIA patients
  per: de Jager, W, et al.
  Publicat: (2011)